GlassScriptPhysician profile
Sachin K Jain
NPI 1326292228
$1,220.29
in general payments reported to CMS, 2019-2025
14 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $234 · 2021: $84.54 · 2022: $53.31 · 2023: $117 · 2024: $121 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $335.63 | 2019-2020 | |
| Allergan, INC. | $176.32 | 2019-2020 | |
| Novo Nordisk INC | $161.72 | 2019-2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $124.69 | 2019-2025 | Freestyle Libre 3 |
| Davol INC. | $117.37 | 2023 | Phasix Mesh |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $83.67 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $45.79 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $40.26 | 2019-2024 | Airsupra |
| Avanir Pharmaceuticals, INC. | $36.28 | 2019 | |
| Philips North America LLC | $35.45 | 2022 | |
| Strongbridge US INC. | $20.72 | 2020 | |
| Shire North American Group INC | $18.66 | 2019 | |
| Horizon Therapeutics Plc | $11.98 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.